Platelet transfusions benefit patients with blood cancers

05/9/2013 | Medscape (free registration)

Prophylactic platelet transfusions lowered the risk of significant bleeding events in patients with blood cancers, according to a study in the New England Journal of Medicine. There was a 7% decrease in the proportion of bleeding events among patients who received platelets. "The results of our study support the need for the continued use of prophylaxis with platelet transfusion and show the benefit of such prophylaxis for reducing bleeding," researchers concluded.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA